US based Dynavax Technologies Corporation, a biopharmaceutical company focused on developing and commercializing novel v...
Taiwan and US-based biopharmaceutical company, Foresee Pharmaceuticals Co., Ltd. (Foresee), recently announced that...
Taiwan based Heroic-Faith which uses deep learning and other forms of AI to develop algorithms that assist in the identi...
Taiwan's Bio Preventive Medicine Corporation (BPM), a leading-edge In Vitro Diagnostics (IVD) company, has announced tha...
Taiwan's Bluesense Diagnostics, ViroTrack Sero COVID-19 IgA+IgM/IgG Ab is an in vitro immuno-magnetic (IMA) as...
ACRO Biomedical Co., Ltd., the first company in the world to utilize “supercritical CO2 extraction technology&rdqu...
D-Link Corporation, a Taiwanese multinational networking equipment manufacturing corporation, has announced the new ...
Why is Taiwan so well under control of the corona crisis despite its geographic proximity to China? Taiwan's former...
General Biologicals Corporation (GBC), a Taiwanese medical device company has developed the GB SARS-CoV-2 Real-Time RT-P...
Genesis Healthcare Co., Japan's leading genetic testing and research company, has announced the launch of its ...
Taiwan absed Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on Next Generation DNA Damage ...
Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, announced that the FDA approved its investiga...
In response to the severe and negative effect that COVID-19 has had on people's physical and mental health, Ta...
Taiwan based startup Deep01, a developer of artificial intelligence (AI) software designed to assist physicians to accur...
NANO-X IMAGING LTD, an innovative medical imaging technology company based in Israel, announces it has signed an exclusi...
The Taiwan External Trade Development Council (TAITRA) has announced the launch of the "Taiwan Anti-COVID-19 Pavilion." ...
HONG KONG Prevalence CVD, including heart attack and stroke, is the third leading cause of death in Hong Kong (aft...
The Cost of Inaction: Secondary Prevention of Cardiovascular Disease in Asia-Pacific Rehabilitation ...
